| Year |
Citation |
Score |
| 2022 |
Zeng W, Chu TTW, Chow EYK, Hu M, Fok BSP, Chan JCN, Yan BPY, Tomlinson B. Factors Associated with Aspirin Resistance in Hong Kong Chinese Patients with Stable Coronary Heart Disease Using the Multiplate Analyzer and Serum Thromboxane B. Pharmaceutics. 14. PMID 36297534 DOI: 10.3390/pharmaceutics14102099 |
0.425 |
|
| 2022 |
Zeng W, Hu M, Lee HK, Wat E, Lau CBS, Ho CS, Wong CK, Tomlinson B. Effects of Soy Isoflavones and Green Tea Extract on Simvastatin Pharmacokinetics and Influence of the SLCO1B1 521T > C Polymorphism. Frontiers in Nutrition. 9: 868126. PMID 35685887 DOI: 10.3389/fnut.2022.868126 |
0.44 |
|
| 2022 |
Zeng W, Hu M, Lee HK, Wat E, Lau CBS, Ho CS, Wong CK, Tomlinson B. Effect of Green Tea Extract and Soy Isoflavones on the Pharmacokinetics of Rosuvastatin in Healthy Volunteers. Frontiers in Nutrition. 9: 850318. PMID 35399656 DOI: 10.3389/fnut.2022.850318 |
0.434 |
|
| 2021 |
Tam CHT, Lim CKP, Luk AOY, Ng ACW, Lee HM, Jiang G, Lau ESH, Fan B, Wan R, Kong APS, Tam WH, Ozaki R, Chow EYK, Lee KF, Siu SC, ... ... Tomlinson B, et al. Development of genome-wide polygenic risk scores for lipid traits and clinical applications for dyslipidemia, subclinical atherosclerosis, and diabetes cardiovascular complications among East Asians. Genome Medicine. 13: 29. PMID 33608049 DOI: 10.1186/s13073-021-00831-z |
0.417 |
|
| 2019 |
Hagger MS, Hamilton K, Hardcastle SJ, Hu M, Kwok S, Lin J, Nawawi HM, Pang J, Santos RD, Soran H, Su TC, Tomlinson B, Watts GF. Predicting intention to participate in self-management behaviors in patients with Familial Hypercholesterolemia: A cross-national study. Social Science & Medicine (1982). 242: 112591. PMID 31630009 DOI: 10.1016/J.Socscimed.2019.112591 |
0.481 |
|
| 2019 |
Fruchart JC, Santos RD, Aguilar-Salinas C, Aikawa M, Al Rasadi K, Amarenco P, Barter PJ, Ceska R, Corsini A, Després JP, Duriez P, Eckel RH, Ezhov MV, Farnier M, Ginsberg HN, ... ... Tomlinson B, et al. The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation. Cardiovascular Diabetology. 18: 71. PMID 31164165 DOI: 10.1186/S12933-019-0864-7 |
0.336 |
|
| 2019 |
Wang Y, Yan BP, Tomlinson B, Lee VW. Is lipid goal one-size-fits-all: A review of evidence for recommended low-density lipoprotein treatment targets in Asian patients. European Journal of Preventive Cardiology. 2047487319843077. PMID 31023098 DOI: 10.1177/2047487319843077 |
0.33 |
|
| 2019 |
Pang J, Chan DC, Hu M, Muir LA, Kwok S, Charng MJ, Florkowski CM, George PM, Lin J, Loi DD, Marais AD, Nawawi HM, Gonzalez-Santos LE, Su TC, Truong TH, ... ... Tomlinson B, et al. Comparative aspects of the care of familial hypercholesterolemia in the "Ten Countries Study". Journal of Clinical Lipidology. PMID 30797720 DOI: 10.1016/J.Jacl.2019.01.009 |
0.363 |
|
| 2019 |
Tomlinson B, Hu M, Chow E. Current status of familial hypercholesterolemia in Chinese populations. Current Opinion in Lipidology. PMID 30649024 DOI: 10.1097/Mol.0000000000000580 |
0.407 |
|
| 2018 |
Chan P, Shao L, Tomlinson B, Zhang Y, Liu ZM. Metformin transporter pharmacogenomics: insights into drug disposition - where are we now? Expert Opinion On Drug Metabolism & Toxicology. PMID 30375241 DOI: 10.1080/17425255.2018.1541981 |
0.301 |
|
| 2018 |
Hagger MS, Hardcastle SJ, Hu M, Kwok S, Lin J, Nawawi HM, Pang J, Santos RD, Soran H, Su TC, Tomlinson B, Watts GF. Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia. Atherosclerosis. 277: 493-501. PMID 30270090 DOI: 10.1016/J.Atherosclerosis.2018.06.010 |
0.471 |
|
| 2018 |
Hagger MS, Hardcastle SJ, Hu M, Kwok S, Lin J, Nawawi HM, Pang J, Santos RD, Soran H, Su TC, Tomlinson B, Watts GF. Health literacy in familial hypercholesterolemia: A cross-national study. European Journal of Preventive Cardiology. 2047487318766954. PMID 29592531 DOI: 10.1177/2047487318766954 |
0.457 |
|
| 2017 |
Tomlinson B, Hu M, Chan J, Mcintyre A, Hegele R. Severe familial hypercholesterolaemia in two brothers with three heterozygous coding mutations in LDLR. Atherosclerosis. 263: e230. PMID 29365890 DOI: 10.1016/J.Atherosclerosis.2017.06.749 |
0.432 |
|
| 2017 |
Tomlinson B, Hu M, Chan J, Mcintyre A, Hegele R. Severe hypertriglycerideamia related to a novel mutation in TRIB1 and a known variant in APOA5. Atherosclerosis. 263: e230. PMID 29365889 DOI: 10.1016/J.Atherosclerosis.2017.06.748 |
0.442 |
|
| 2017 |
Chan P, Shao L, Tomlinson B, Liu ZM. The ODYSSEY DM-DYSLIPIDEMIA trial: confirming the benefits of alirocumab in diabetic mixed dyslipidemia. Annals of Translational Medicine. 5: 477. PMID 29285510 DOI: 10.21037/Atm.2017.10.26 |
0.332 |
|
| 2017 |
Pang J, Hu M, Lin J, Miida T, Nawawi HM, Park JE, Wu X, Ramli AS, Kim NT, Kwok S, Gonzalez-Santos LE, Su TC, Truong TH, Soran H, Yamashita S, ... Tomlinson B, et al. An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the "Ten Countries Study". Bmj Open. 7: e017817. PMID 29074516 DOI: 10.1136/Bmjopen-2017-017817 |
0.43 |
|
| 2017 |
Griffith JF, Hu M, Yeung DKW, Guo P, Lam SL, Xiao F, Wang D, Tomlinson B. Achilles Tendon Xanthomas: Fat-Water Separation at Baseline and After Treatment. Radiology. 161435. PMID 28825891 DOI: 10.1148/Radiol.2017161435 |
0.397 |
|
| 2017 |
Tomlinson B, Hu M, Zhang Y, Chan P, Liu ZM. Evolocumab for the treatment of hypercholesterolemia. Expert Opinion On Biological Therapy. 1-15. PMID 28812389 DOI: 10.1080/14712598.2017.1365134 |
0.53 |
|
| 2017 |
Tomlinson B, Hu M, Zhang Y, Chan P, Liu ZM. Alirocumab for the treatment of hypercholesterolaemia. Expert Opinion On Biological Therapy. PMID 28277798 DOI: 10.1080/14712598.2017.1305354 |
0.532 |
|
| 2016 |
Tomlinson B, Hu M, Zhang Y, Chan P, Liu ZM. Liraglutide for weight management: benefits and risks. Current Medical Research and Opinion. 1-9. PMID 27936966 DOI: 10.1080/03007995.2016.1271315 |
0.448 |
|
| 2016 |
Wang TD, Tan RS, Lee HY, Ihm SH, Rhee MY, Tomlinson B, Pal P, Yang F, Hirschhorn E, Prescott MF, Hinder M, Langenickel TH. Effects of Sacubitril/Valsartan (LCZ696) on Natriuresis, Diuresis, Blood Pressures, and NT-proBNP in Salt-Sensitive Hypertension. Hypertension (Dallas, Tex. : 1979). PMID 27849566 DOI: 10.1161/Hypertensionaha.116.08484 |
0.301 |
|
| 2016 |
Tomlinson B, Hu M, Zhang Y, Chan P, Liu ZM. Evaluation of the pharmacokinetics, pharmacodynamics and clinical efficacy of empagliflozin for the treatment of type 2 diabetes. Expert Opinion On Drug Metabolism & Toxicology. PMID 27817207 DOI: 10.1080/17425255.2017.1258401 |
0.507 |
|
| 2016 |
Zeng W, Chu T, Hu M, Kong A, Tomlinson B. OS 31-02 ANTIHYPERTENSIVE RESPONSE TO BISOPROLOL WAS NOT RELATED TO POLYMORPHISMS IN ADRB1 Or CYP2D6 IN CHINESE HYPERTENSIVE PATIENTS. Journal of Hypertension. 34: e388. PMID 27754210 DOI: 10.1097/01.hjh.0000500990.24186.18 |
0.453 |
|
| 2016 |
Kuang Y, Li X, Chen X, Sun H, Tomlinson B, Chan P, Zheng L, Pi J, Peng S, Wu H, Ding X, Qian D, Shen Y, Yu Z, Fan L, et al. Higher prevalence of elevated LDL-C than non-HDL-C and low statin treatment rate in elderly community-dwelling Chinese with high cardiovascular risk. Scientific Reports. 6: 34268. PMID 27686151 DOI: 10.1038/Srep34268 |
0.31 |
|
| 2016 |
Hu M, Lee HK, To KK, Fok BS, Wo SK, Ho CS, Wong CK, Zuo Z, Chan TY, Chan JC, Tomlinson B. Telmisartan increases systemic exposure to rosuvastatin after single and multiple doses, and in vitro studies show telmisartan inhibits ABCG2-mediated transport of rosuvastatin. European Journal of Clinical Pharmacology. PMID 27651239 DOI: 10.1007/S00228-016-2130-1 |
0.471 |
|
| 2016 |
Zeng W, Chu T, Hu M, Kong A, Tomlinson B. OS 31-02 ANTIHYPERTENSIVE RESPONSE TO BISOPROLOL WAS NOT RELATED TO POLYMORPHISMS IN ADRB1 Or CYP2D6 IN CHINESE HYPERTENSIVE PATIENTS. Journal of Hypertension. 34: e388. PMID 27643167 DOI: 10.1097/01.Hjh.0000500990.24186.18 |
0.516 |
|
| 2016 |
Tomlinson B, Hu M, Zhang Y, Chan P, Liu ZM. Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes. Expert Opinion On Drug Metabolism & Toxicology. PMID 27607315 DOI: 10.1080/17425255.2016.1234608 |
0.491 |
|
| 2016 |
Tomlinson B, Hu M, Zhang Y, Chan P, Liu ZM. Investigational glucagon-like peptide-1 agonists for the treatment of obesity. Expert Opinion On Investigational Drugs. 1-13. PMID 27563838 DOI: 10.1080/13543784.2016.1221925 |
0.468 |
|
| 2016 |
Chan SW, Xiao Y, Hu M, Yin OQ, Chu TT, Fok BS, Lee VH, Tomlinson B. Associations of the CYP3A5*3 and CYP3A4*1G polymorphisms with the pharmacokinetics of oral midazolam and the urinary 6β-hydroxycortisol/cortisol ratio as markers of CYP3A activity in healthy male Chinese. Journal of Clinical Pharmacy and Therapeutics. PMID 27511886 DOI: 10.1111/Jcpt.12433 |
0.63 |
|
| 2016 |
Watts GF, Ding PY, George P, Hagger MS, Hu M, Lin J, Khoo KL, Marais AD, Miida T, Nawawi HM, Pang J, Park JE, Gonzalez-Santos LB, Su TC, Truong TH, ... ... Tomlinson B, et al. Translational Research for Improving the Care of Familial Hypercholesterolemia: The "Ten Countries Study" and Beyond. Journal of Atherosclerosis and Thrombosis. PMID 27384016 DOI: 10.5551/Jat.35949 |
0.475 |
|
| 2016 |
Lam KS, Chow CC, Tan KC, Ma RC, Kong AP, Tong PC, Tsang MW, Chan TM, Tang SC, Lee KK, So WY, Tomlinson B. Practical considerations for the use of SGLT2 inhibitors in treating hyperglycaemia in type 2 diabetes. Current Medical Research and Opinion. 1-49. PMID 26933918 DOI: 10.1185/03007995.2016.1161608 |
0.3 |
|
| 2016 |
Tomlinson B, Hu M, Zhang Y, Liu ZM, Chan P. Response to the letter "No evidence to support high-intensity statin in Chinese patients with coronary heart disease". International Journal of Cardiology. 209: 192-193. PMID 26896621 DOI: 10.1016/J.Ijcard.2016.02.047 |
0.462 |
|
| 2016 |
Hu M, Hooper AJ, Bockxmeer FM, Watts GF, Chan JC, Tomlinson B. Management of Familial Hypercholesterolemia in Hong Kong. Journal of Atherosclerosis and Thrombosis. PMID 26875521 DOI: 10.5551/Jat.34314 |
0.53 |
|
| 2016 |
Hu M, Tam C, So W, Chan J, Tomlinson B, Ma R. Genetic variants and lipid traits in the Hong Kong Chinese patients with type 2 diabetes Atherosclerosis. 252: e148. DOI: 10.1016/J.Atherosclerosis.2016.07.729 |
0.504 |
|
| 2016 |
Hu M, Chan J, Tomlinson B. Rare variants in ABCG2 identified by sequencing may influence the lipid response to rosuvastatin treatment Atherosclerosis. 252: e202-e203. DOI: 10.1016/J.Atherosclerosis.2016.07.125 |
0.479 |
|
| 2015 |
Tomlinson B, Hu M, Zhang Y, Chan P, Liu ZM. An overview of novel GLP-1 receptor agonists for type II diabetes. Expert Opinion On Investigational Drugs. PMID 26587691 DOI: 10.1517/13543784.2016.1123249 |
0.49 |
|
| 2015 |
Hu M, Fok BS, Wo SK, Lee VH, Zuo Z, Tomlinson B. Effect of common polymorphisms of the farnesoid X receptor and bile acid transporters on the pharmacokinetics of ursodeoxycholic acid. Clinical and Experimental Pharmacology & Physiology. PMID 26382575 DOI: 10.1111/1440-1681.12490 |
0.505 |
|
| 2015 |
Ding C, Hu M, Wu YJ, Tomlinson B. Achievement of specified lipid and high-sensitivity C-reactive protein levels with two statins in Chinese patients with hypercholesterolaemia. Lipids in Health and Disease. 14: 107. PMID 26365713 DOI: 10.1186/S12944-015-0116-0 |
0.507 |
|
| 2015 |
Wang D, Shi L, Chu WC, Hu M, Tomlinson B, Huang WH, Wang T, Heng PA, Yeung DK, Ahuja AT. Fully automatic and nonparametric quantification of adipose tissue in fat-water separation MR imaging. Medical & Biological Engineering & Computing. PMID 26245254 DOI: 10.1007/S11517-015-1347-Y |
0.579 |
|
| 2015 |
Hu M, Yang YL, Chan P, Tomlinson B. Pharmacogenetics of cutaneous flushing response to niacin/laropiprant combination in Hong Kong Chinese patients with dyslipidemia. Pharmacogenomics. 16: 1387-97. PMID 26226939 DOI: 10.2217/Pgs.15.79 |
0.496 |
|
| 2015 |
Hu M, Yang YL, Masuda D, Yamashita S, Tomlinson B. Effect of Extended-Release Niacin/Laropiprant Combination on Plasma Adiponectin and Insulin Resistance in Chinese Patients with Dyslipidaemia. Disease Markers. 2015: 154014. PMID 26063948 DOI: 10.1155/2015/154014 |
0.475 |
|
| 2015 |
Hu M, Yang YL, Ng CF, Lee CP, Lee VW, Hanada H, Masuda D, Yamashita S, Tomlinson B. Effects of phenotypic and genotypic factors on the lipid responses to niacin in chinese patients with dyslipidemia. Medicine. 94: e881. PMID 25997070 DOI: 10.1097/Md.0000000000000881 |
0.536 |
|
| 2015 |
Liu ZM, Hu M, Chan P, Tomlinson B. Early investigational drugs targeting PPAR-α for the treatment of metabolic disease. Expert Opinion On Investigational Drugs. 24: 611-21. PMID 25604802 DOI: 10.1517/13543784.2015.1006359 |
0.475 |
|
| 2015 |
Ding C, Hu M, Wu YJ, Tomlinson B. Achievement of specified lipid and high-sensitivity C-reactive protein levels with two statins in Chinese patients with hypercholesterolaemia Lipids in Health and Disease. 14. DOI: 10.1186/s12944-015-0116-0 |
0.436 |
|
| 2015 |
Hu M, Fok B, Wo S, Lee V, Zuo Z, Tomlinson B. Influence of farnesoid X receptor and bile acid transporter polymorphisms on the pharmacokinetics of ursodeoxycholic acid Atherosclerosis. 241: e118. DOI: 10.1016/J.Atherosclerosis.2015.04.411 |
0.458 |
|
| 2015 |
Hu M, Yang Y, Masuda D, Yamashita S, Tomlinson B. Is there a role for niacin in familial hypercholesterolaemia? Atherosclerosis. 241: e109. DOI: 10.1016/J.Atherosclerosis.2015.04.383 |
0.438 |
|
| 2014 |
Hu M, Tomlinson B. Niacin for reduction of cardiovascular risk. The New England Journal of Medicine. 371: 1941-2. PMID 25390751 DOI: 10.1056/Nejmc1411240#Sa3 |
0.382 |
|
| 2014 |
Xiao YJ, Hu M, Tomlinson B. Effects of grapefruit juice on cortisol metabolism in healthy male Chinese subjects. Food and Chemical Toxicology : An International Journal Published For the British Industrial Biological Research Association. 74: 85-90. PMID 25265455 DOI: 10.1016/J.Fct.2014.09.012 |
0.622 |
|
| 2014 |
To KK, Hu M, Tomlinson B. Expression and activity of ABCG2, but not ABCB1 or OATP1B1, are associated with cholesterol levels: evidence from in vitro and in vivo experiments. Pharmacogenomics. 15: 1091-104. PMID 25084202 DOI: 10.2217/Pgs.14.58 |
0.51 |
|
| 2014 |
Hu M, Yuen YP, Kwok JS, Griffith JF, Tomlinson B. Potential effects of NPC1L1 polymorphisms in protecting against clinical disease in a chinese family with sitosterolaemia. Journal of Atherosclerosis and Thrombosis. 21: 989-95. PMID 25056759 DOI: 10.5551/Jat.24679 |
0.51 |
|
| 2014 |
Hu M, Tomlinson B. Ezetimibe treatment should be considered for patients with sitosterolemia. Pediatric Nephrology (Berlin, Germany). 29: 1469-70. PMID 24839218 DOI: 10.1007/S00467-014-2843-2 |
0.464 |
|
| 2014 |
Hu M, Zeng W, Tomlinson B. Evaluation of a crataegus-based multiherb formula for dyslipidemia: a randomized, double-blind, placebo-controlled clinical trial. Evidence-Based Complementary and Alternative Medicine : Ecam. 2014: 365742. PMID 24834096 DOI: 10.1155/2014/365742 |
0.523 |
|
| 2014 |
Hu M, Tomlinson B. Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin. Expert Opinion On Drug Metabolism & Toxicology. 10: 51-65. PMID 24156555 DOI: 10.1517/17425255.2014.851667 |
0.505 |
|
| 2014 |
Faiz F, Hu M, Hooper AJ, Tomlinson B, Van Bockxmeer FM. Molecular characterization of a Chinese woman homozygous for the familial hypercholesterolemia LDLR c.1474G>A (p.Asp492Asn) mutation Clinical Lipidology. 9: 163-170. DOI: 10.2217/Clp.14.6 |
0.488 |
|
| 2014 |
HU M, Yang Y, Yamashita S, Masuda D, Tomlinson B. Effect of niacin on oxidized low-density lipoprotein levels in Chinese patients with dyslipidaemia Atherosclerosis. 235: e256. DOI: 10.1016/J.Atherosclerosis.2014.05.766 |
0.494 |
|
| 2014 |
Hu M, Yang Y, Ng C, Lee C, Lee V, Tomlinson B. DGAT1 and DGAT2 polymorphisms had no effect on the lipid responses to niacin in Chinese patients with dyslipidaemia Atherosclerosis. 235: e256. DOI: 10.1016/J.Atherosclerosis.2014.05.765 |
0.533 |
|
| 2014 |
Zeng W, Hu M, Tomlinson B. Pharmacogenetics of antihypertensive therapies: Can this be applied in the clinic? Current Pharmacogenomics and Personalized Medicine. 12: 72-88. |
0.445 |
|
| 2013 |
Yang YL, Hu M, Chang M, Tomlinson B. A high incidence of exanthematous eruption associated with niacin/laropiprant combination in Hong Kong Chinese patients. Journal of Clinical Pharmacy and Therapeutics. 38: 528-32. PMID 24020480 DOI: 10.1111/Jcpt.12096 |
0.495 |
|
| 2013 |
Hu M, Tomlinson B. Lipid-lowing pharmacogenomics in Chinese patients. Expert Review of Cardiovascular Therapy. 11: 985-97. PMID 23952137 DOI: 10.1586/14779072.2013.814839 |
0.503 |
|
| 2013 |
Lee HK, Hu M, Lui SSh, Ho CS, Wong CK, Tomlinson B. Effects of polymorphisms in ABCG2, SLCO1B1, SLC10A1 and CYP2C9/19 on plasma concentrations of rosuvastatin and lipid response in Chinese patients. Pharmacogenomics. 14: 1283-94. PMID 23930675 DOI: 10.2217/Pgs.13.115 |
0.533 |
|
| 2013 |
Hu M, Tomlinson B. Pharmacogenomics of lipid-lowering therapies. Pharmacogenomics. 14: 981-95. PMID 23746191 DOI: 10.2217/Pgs.13.71 |
0.533 |
|
| 2013 |
Lee HK, Ho CS, Hu M, Tomlinson B, Wong CK. Development and validation of a sensitive method for simultaneous determination of rosuvastatin and N-desmethyl rosuvastatin in human plasma using liquid chromatography/negative electrospray ionization/tandem mass spectrometry. Biomedical Chromatography : Bmc. 27: 1369-74. PMID 23722358 DOI: 10.1002/Bmc.2944 |
0.449 |
|
| 2013 |
Hu M, Lui SS, Ko GT, Tomlinson B. Do the lipid responses to rosuvastatin and atorvastatin differ between Chinese and Caucasians? Comparison of the DISCOVERY-Hong Kong study with other DISCOVERY studies. International Journal of Cardiology. 168: 3071-3. PMID 23642826 DOI: 10.1016/J.Ijcard.2013.04.091 |
0.511 |
|
| 2013 |
Hu M, Tomlinson B. Current Perspectives on rosuvastatin. Integrated Blood Pressure Control. 6: 15-25. PMID 23637557 DOI: 10.2147/IBPC.S34814 |
0.47 |
|
| 2013 |
Ma RC, Hu C, Tam CH, Zhang R, Kwan P, Leung TF, Thomas GN, Go MJ, Hara K, Sim X, Ho JS, Wang C, Li H, Lu L, Wang Y, ... ... Tomlinson B, et al. Genome-wide association study in a Chinese population identifies a susceptibility locus for type 2 diabetes at 7q32 near PAX4. Diabetologia. 56: 1291-305. PMID 23532257 DOI: 10.1007/S00125-013-2874-4 |
0.537 |
|
| 2013 |
Leng XY, Chen XY, Chook P, Xiong L, Lin WH, Liu JY, Tomlinson B, Thomas GN, Lam TH, Lam KS, Cheung BM, Wong KS. Association between metabolic syndrome and carotid atherosclerosis: a community-based study in Hong Kong. Metabolic Syndrome and Related Disorders. 11: 109-14. PMID 23350809 DOI: 10.1089/Met.2012.0099 |
0.505 |
|
| 2013 |
Hu M, Mak VW, Xiao Y, Tomlinson B. Associations between the genotypes and phenotype of CYP3A and the lipid response to simvastatin in Chinese patients with hypercholesterolemia. Pharmacogenomics. 14: 25-34. PMID 23252946 DOI: 10.2217/Pgs.12.181 |
0.664 |
|
| 2013 |
Leng XY, Chen XY, Chook P, Xiong L, Lin WH, Liu JY, Tomlinson B, Thomas GN, Lam TH, Lam KS, Cheung BM, Wong KS. Correlation of large artery intracranial occlusive disease with carotid intima-media thickness and presence of carotid plaque. Stroke; a Journal of Cerebral Circulation. 44: 68-72. PMID 23168454 DOI: 10.1161/Strokeaha.112.675652 |
0.47 |
|
| 2013 |
Chan SW, Hu M, Ko SS, Tam CW, Fok BS, Yin OQ, Chow MS, Tomlinson B. CYP2C19 genotype has a major influence on labetalol pharmacokinetics in healthy male Chinese subjects. European Journal of Clinical Pharmacology. 69: 799-806. PMID 23090703 DOI: 10.1007/S00228-012-1428-X |
0.501 |
|
| 2013 |
Hu M, Mak VW, Yin OQ, Chu TT, Tomlinson B. Effects of grapefruit juice and SLCO1B1 388A>G polymorphism on the pharmacokinetics of pitavastatin. Drug Metabolism and Pharmacokinetics. 28: 104-8. PMID 22850760 DOI: 10.2133/Dmpk.Dmpk-12-Rg-067 |
0.513 |
|
| 2013 |
Hu M, Lan W, Lam CW, Mak YT, Pang CP, Tomlinson B. Heterozygous familial hypercholesterolemia in Hong Kong Chinese. Study of 252 cases. International Journal of Cardiology. 167: 762-7. PMID 22464486 DOI: 10.1016/J.Ijcard.2012.03.048 |
0.637 |
|
| 2013 |
Zeng W, Hu M, Yang Y, Tomlinson B. Review of cases of rhabdomyolysis admitted to the Prince of Wales Hospital International Journal of Cardiology. 164: S30. DOI: 10.1016/S0167-5273(13)70606-5 |
0.415 |
|
| 2013 |
Yang Y, Hu M, Tomlinson B. Lipid-modifying effects of nicotinic acid with laropiprant in Hong Kong Chinese patients with dyslipidaemia International Journal of Cardiology. 164: S16. DOI: 10.1016/S0167-5273(13)70569-2 |
0.487 |
|
| 2012 |
Hu M, Cheung BM, Tomlinson B. Safety of statins: an update. Therapeutic Advances in Drug Safety. 3: 133-44. PMID 25083232 DOI: 10.1177/2042098612439884 |
0.515 |
|
| 2012 |
Hu M, Mak VW, Tomlinson B. Polymorphisms in apolipoprotein E and apolipoprotein A-V do not influence the lipid response to rosuvastatin but are associated with baseline lipid levels in Chinese patients with hyperlipidemia. Journal of Clinical Lipidology. 6: 585-92. PMID 23312054 DOI: 10.1016/J.Jacl.2012.02.005 |
0.523 |
|
| 2012 |
Hu M, Fan L, Zhou HH, Tomlinson B. Theranostics meets traditional Chinese medicine: rational prediction of drug-herb interactions. Expert Review of Molecular Diagnostics. 12: 815-30. PMID 23249200 DOI: 10.1586/Erm.12.126 |
0.482 |
|
| 2012 |
Hu M, Mak VW, Tomlinson B. Comments on "CYP3AP1*3 allele is associated with lipid-lowering efficacy of simvastatin and atorvastatin in Chinese women". Journal of Clinical Pharmacology. 52: 1768-9; author reply. PMID 23105125 DOI: 10.1177/0091270011415411 |
0.431 |
|
| 2012 |
Hu M, Tomlinson B. Effects of statin treatments and polymorphisms in UGT1A1 and SLCO1B1 on serum bilirubin levels in Chinese patients with hypercholesterolaemia. Atherosclerosis. 223: 427-32. PMID 22749334 DOI: 10.1016/J.Atherosclerosis.2012.06.002 |
0.525 |
|
| 2012 |
Hu M, Yang YL, Fok BS, Chan SW, Chu TT, Poon EW, Yin OQ, Lee VH, Tomlinson B. Effects of CYP2D6*10, CYP3A5*3, CYP1A2*1F, and ABCB1 C3435T polymorphisms on the pharmacokinetics of flecainide in healthy Chinese subjects. Drug Metabolism and Drug Interactions. 27: 33-9. PMID 22718623 DOI: 10.1515/Dmdi-2011-0032 |
0.515 |
|
| 2012 |
Hu M, Mak VW, Tomlinson B. Intronic variants in SLCO1B1 related to statin-induced myopathy are associated with the low-density lipoprotein cholesterol response to statins in Chinese patients with hyperlipidaemia. Pharmacogenetics and Genomics. 22: 803-6. PMID 22668755 DOI: 10.1097/Fpc.0B013E3283557C98 |
0.541 |
|
| 2012 |
Chan SW, Hu M, Tomlinson B. The pharmacogenetics of β-adrenergic receptor antagonists in the treatment of hypertension and heart failure. Expert Opinion On Drug Metabolism & Toxicology. 8: 767-90. PMID 22621216 DOI: 10.1517/17425255.2012.685157 |
0.488 |
|
| 2012 |
Ambegaonkar B, Chirovsky D, Tse HF, Lau YK, Tomlinson B, Li SK, Yue CS, Wong TH, Choi MC, Tunggal P, Sazonov V. Attainment of normal lipid levels among patients on lipid-modifying therapy in Hong Kong. Advances in Therapy. 29: 427-41. PMID 22562782 DOI: 10.1007/S12325-012-0017-9 |
0.325 |
|
| 2012 |
Hu M, Lui SS, Tam LS, Li EK, Tomlinson B. The farnesoid X receptor -1G>T polymorphism influences the lipid response to rosuvastatin. Journal of Lipid Research. 53: 1384-9. PMID 22534644 DOI: 10.1194/Jlr.M026054 |
0.53 |
|
| 2012 |
Wang D, Zhuang Y, Tian Y, Thomas GN, Ying M, Tomlinson B. Study of the effects of total flavonoids of Astragalus on atherosclerosis formation and potential mechanisms. Oxidative Medicine and Cellular Longevity. 2012: 282383. PMID 22496932 DOI: 10.1155/2012/282383 |
0.536 |
|
| 2012 |
Guo Y, Tomlinson B, Chu T, Fang YJ, Gui H, Tang CS, Yip BH, Cherny SS, Hur YM, Sham PC, Lam TH, Thomas NG. A genome-wide linkage and association scan reveals novel loci for hypertension and blood pressure traits. Plos One. 7: e31489. PMID 22384028 DOI: 10.1371/Journal.Pone.0031489 |
0.537 |
|
| 2012 |
Hu M, Chu WC, Yamashita S, Yeung DK, Shi L, Wang D, Masuda D, Yang Y, Tomlinson B. Liver fat reduction with niacin is influenced by DGAT-2 polymorphisms in hypertriglyceridemic patients. Journal of Lipid Research. 53: 802-9. PMID 22315393 DOI: 10.1194/Jlr.P023614 |
0.627 |
|
| 2012 |
Yin OQ, Mak VW, Hu M, Fok BS, Chow MS, Tomlinson B. Impact of CYP2D6 polymorphisms on the pharmacokinetics of lovastatin in Chinese subjects. European Journal of Clinical Pharmacology. 68: 943-9. PMID 22281720 DOI: 10.1007/S00228-011-1202-5 |
0.534 |
|
| 2012 |
Hu M, Wang DQ, Xiao YJ, Mak VW, Tomlinson B. Herb-drug interactions: methods to identify potential influence of genetic variations in genes encoding drug metabolizing enzymes and drug transporters. Current Pharmaceutical Biotechnology. 13: 1718-30. PMID 22039823 DOI: 10.2174/138920112800958805 |
0.679 |
|
| 2012 |
Chu TT, Benzie IF, Lam CW, Fok BS, Lee KK, Tomlinson B. Study of potential cardioprotective effects of Ganoderma lucidum (Lingzhi): results of a controlled human intervention trial. The British Journal of Nutrition. 107: 1017-27. PMID 21801467 DOI: 10.1017/S0007114511003795 |
0.334 |
|
| 2012 |
Lee VWY, Hu M, Tomlinson B. Integrating pharmacogenetics for assessment of herb-drug interactions: Has the time come? Current Pharmacogenomics and Personalized Medicine. 10: 247-253. DOI: 10.2174/187569212802509988 |
0.49 |
|
| 2012 |
Xiao Y, Chan SW, Hu M, Chu TTW, Fok BSP, Poon EWM, Tomlinson B. Simultaneous determination of cortisol, cortisone, and 6β- hydroxycortisol in human urine by UPLC with UV detector and application to determine diurnal variations Chromatographia. 75: 169-173. DOI: 10.1007/S10337-011-2162-8 |
0.598 |
|
| 2011 |
Yang Y, Chan SW, Hu M, Walden R, Tomlinson B. Effects of some common food constituents on cardiovascular disease. Isrn Cardiology. 2011: 397136. PMID 22347642 DOI: 10.5402/2011/397136 |
0.482 |
|
| 2011 |
Hu M, Mak VWL, Tomlinson B. Simvastatin-induced myopathy, the role of interaction with diltiazem and genetic predisposition Journal of Clinical Pharmacy and Therapeutics. 36: 419-425. PMID 21545622 DOI: 10.1111/J.1365-2710.2010.01184.X |
0.508 |
|
| 2011 |
Deng HB, Jiang CQ, Tomlinson B, Liu B, Lin JM, Wong KS, Cheung BM, Lam TH, Thomas GN. A polymorphism in transforming growth factor-β1 is associated with carotid plaques and increased carotid intima-media thickness in older Chinese men: the Guangzhou Biobank Cohort Study-Cardiovascular Disease Subcohort. Atherosclerosis. 214: 391-6. PMID 21167485 DOI: 10.1016/J.Atherosclerosis.2010.11.025 |
0.301 |
|
| 2011 |
Hu M, To KK, Mak VW, Tomlinson B. The ABCG2 transporter and its relations with the pharmacokinetics, drug interaction and lipid-lowering effects of statins. Expert Opinion On Drug Metabolism & Toxicology. 7: 49-62. PMID 21091277 DOI: 10.1517/17425255.2011.538383 |
0.497 |
|
| 2011 |
Hu M, Thomas GN, Tomlinson B. Lipid disorders in Chinese populations Clinical Lipidology. 6: 549-562. DOI: 10.2217/Clp.11.47 |
0.528 |
|
| 2011 |
Hu M, Mak V, Poon E, Tomlinson B. 110 ASSOCIATIONS OF APOE POLYMORPHISMS WITH BASELINE LIPIDS AND RESPONSE TO ROSUVASTATIN VARY IN CHINESE PATIENTS WITH AND WITHOUT FAMILIAL HYPERCHOLESTEROLAEMIA Atherosclerosis Supplements. 12: 26. DOI: 10.1016/S1567-5688(11)70111-8 |
0.528 |
|
| 2011 |
Yang Y, Hu M, Chan S, Fok B, Chu T, Lee V, Tomlinson B. P062 Flecainide Pharmacokinetics are Influenced by CYP3A5 and ABCB1 Polymorphisms International Journal of Cardiology. 147: S26. DOI: 10.1016/S0167-5273(11)70088-2 |
0.49 |
|
| 2010 |
Hu M, Lee MH, Mak VW, Tomlinson B. Effect of central obesity, low high-density lipoprotein cholesterol and C-reactive protein polymorphisms on C-reactive protein levels during treatment with Rosuvastatin (10 mg Daily). The American Journal of Cardiology. 106: 1588-93. PMID 21094359 DOI: 10.1016/J.Amjcard.2010.07.044 |
0.554 |
|
| 2010 |
Hu M, Tomlinson B. Growth hormone-releasing factor agonists for the treatment of HIV-associated lipodystrophy. Current Opinion in Investigational Drugs (London, England : 2000). 11: 1143-50. PMID 20872317 |
0.4 |
|
| 2010 |
Hu M, Tomlinson B. Pharmacokinetic evaluation of lanreotide. Expert Opinion On Drug Metabolism & Toxicology. 6: 1301-12. PMID 20716034 DOI: 10.1517/17425255.2010.513700 |
0.438 |
|
| 2010 |
Hu M, Lui SS, Mak VW, Chu TT, Lee VW, Poon EW, Tsui TK, Ko GT, Baum L, Tam LS, Li EK, Tomlinson B. Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients. Pharmacogenetics and Genomics. 20: 634-7. PMID 20679960 DOI: 10.1097/Fpc.0B013E32833De489 |
0.537 |
|
| 2010 |
Jiang CQ, Liu B, Cheung BM, Lam TH, Lin JM, Li Jin Y, Yue XJ, Ong KL, Tam S, Wong KS, Tomlinson B, Lam KS, Thomas GN. A single nucleotide polymorphism in APOA5 determines triglyceride levels in Hong Kong and Guangzhou Chinese. European Journal of Human Genetics : Ejhg. 18: 1255-60. PMID 20571505 DOI: 10.1038/Ejhg.2010.93 |
0.352 |
|
| 2010 |
Fang YJ, Deng HB, Thomas GN, Tzang CH, Li CX, Xu ZL, Yang M, Tomlinson B. Linkage of angiotensinogen gene polymorphisms with hypertension in a sibling study of Hong Kong Chinese. Journal of Hypertension. 28: 1203-9. PMID 20216084 DOI: 10.1097/Hjh.0B013E3283384B07 |
0.539 |
|
| 2010 |
You JH, Chan WK, Chung PF, Hu M, Tomlinson B. Effects of concomitant therapy with diltiazem on the lipid responses to simvastatin in Chinese subjects. Journal of Clinical Pharmacology. 50: 1151-8. PMID 20150526 DOI: 10.1177/0091270009358082 |
0.53 |
|
| 2010 |
Tomlinson B, Hu M, Lee VW, Lui SS, Chu TT, Poon EW, Ko GT, Baum L, Tam LS, Li EK. ABCG2 polymorphism is associated with the low-density lipoprotein cholesterol response to rosuvastatin. Clinical Pharmacology and Therapeutics. 87: 558-62. PMID 20130569 DOI: 10.1038/Clpt.2009.232 |
0.527 |
|
| 2010 |
Liu ZK, Hu M, Baum L, Thomas GN, Tomlinson B. Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese. Atherosclerosis. 208: 427-32. PMID 19732897 DOI: 10.1016/J.Atherosclerosis.2009.08.013 |
0.482 |
|
| 2010 |
Jiang CQ, Lam TH, Lin JM, Liu B, Yue XJ, Cheng KK, Tomlinson B, Wong KS, Cheung BM, Thomas GN. An overview of the Guangzhou biobank cohort study-cardiovascular disease subcohort (GBCS-CVD): a platform for multidisciplinary collaboration. Journal of Human Hypertension. 24: 139-50. PMID 19587700 DOI: 10.1038/Jhh.2009.52 |
0.307 |
|
| 2009 |
Hu M, Mak V, Chu T, Waye M, Tomlinson B. Pharmacogenetics of HMG-CoA Reductase Inhibitors: Optimizing the Prevention of Coronary Heart Disease Current Pharmacogenomics and Personalized Medicine. 7: 1-26. DOI: 10.2174/187569209787582349 |
0.529 |
|
| 2009 |
Mak V, Hu M, Chu T, Poon E, Tsui T, Tomlinson B. Abstract: P487 EFFECTS OF COMMON SINGLE NUCLEOTIDE POLYMORPHISMS AND HAPLOTYPES OF SLCO1B1 IN CHINESE ON THE PLASMA LIPID RESPONSES TO SIMVASTATIN Atherosclerosis Supplements. 10: e800. DOI: 10.1016/S1567-5688(09)70782-2 |
0.521 |
|
| 2009 |
Hu M, Mak V, Poon E, Chu T, Tsui T, Tomlinson B. Abstract: P486 GENETIC DETERMINANTS OF LIPID RESPONSE TO ROSUVASTATIN IN CHINESE PATIENTS WITH HYPERCHOLESTEROLAEMIA Atherosclerosis Supplements. 10: e799. DOI: 10.1016/S1567-5688(09)70781-0 |
0.503 |
|
| 2009 |
Tomlinson B, Hu M, Mak V, Chu T, Lee V. Abstract: 36 EFFECTS OF GENETIC VARIANTS IN DRUG METABOLIZING ENZYMES AND TRANSPORTERS ON STATIN SAFETY AND EFFICACY Atherosclerosis Supplements. 10: e19. DOI: 10.1016/S1567-5688(09)70026-1 |
0.487 |
|
| 2008 |
Hu M, Tomlinson B. Febuxostat in the management of hyperuricemia and chronic gout: a review. Therapeutics and Clinical Risk Management. 4: 1209-20. PMID 19337428 DOI: 10.2147/Tcrm.S3310 |
0.489 |
|
| 2008 |
Zhao HL, Sui Y, Guan J, He L, Lai FM, Zhong DR, Yang D, Baum L, Tong PC, Tomlinson B, Chan JC. Higher islet amyloid load in men than in women with type 2 diabetes mellitus. Pancreas. 37: e68-73. PMID 18815541 DOI: 10.1097/Mpa.0B013E3181788E18 |
0.494 |
|
| 2008 |
Tomlinson B, Hu M, Lee VW. In vivo assessment of herb-drug interactions: possible utility of a pharmacogenetic approach? Molecular Nutrition & Food Research. 52: 799-809. PMID 18618477 DOI: 10.1002/Mnfr.200700454 |
0.487 |
|
| 2008 |
Thomas GN, Tomlinson B. Prevention of macrovascular disease in type 2 diabetic patients: blockade of the renin-angiotensin-aldosterone system. Current Diabetes Reviews. 4: 63-78. PMID 18220697 DOI: 10.2174/157339908783502334 |
0.319 |
|
| 2008 |
Tomlinson B, Mak V, Hu M, Yin O, Chow M. EFFECTS OF EFFLUX TRANSPORTER BCRP C421A POLYMORPHISM ON PITAVASTATIN PHARMACOKINETICS AND INTERACTION WITH GRAPEFRUIT JUICE Atherosclerosis Supplements. 9: 243. DOI: 10.1016/S1567-5688(08)70975-9 |
0.459 |
|
| 2008 |
Hu M, Tomlinson B, Lui S, Ko G. COMPARISON OF THE EFFICACY AND SAFETY OF ROSUVASTATIN WITH ATORVASTATIN FOR ACHIEVING LIPID GOALS: THE DISCOVERY- HONG KONG STUDY Atherosclerosis Supplements. 9: 199. DOI: 10.1016/S1567-5688(08)70796-7 |
0.481 |
|
| 2008 |
Mak V, Hu M, Yin O, Chow M, Tomlinson B. P327 Interaction of pitavastatin with grapefruit juice in subjects with different efflux transporter BCRP ABCG2 421C>A genotypes International Journal of Cardiology. 125: S59. DOI: 10.1016/S0167-5273(08)70238-9 |
0.472 |
|
| 2008 |
Hu M, Tomlinson B, Lui S, Chu T, Poon E, Baum L, Lee V. O105 Pharmacogenetics of lipid responses to rosuvastatin in Chinese patients: effects of polymorphisms in BCRP and CYP2D6 International Journal of Cardiology. 125: S41. DOI: 10.1016/S0167-5273(08)70182-7 |
0.446 |
|
| 2007 |
Zhu JR, Tomlinson B, Ro YM, Sim KH, Lee YT, Sriratanasathavorn C. A randomised study comparing the efficacy and safety of rosuvastatin with atorvastatin for achieving lipid goals in clinical practice in Asian patients at high risk of cardiovascular disease (DISCOVERY-Asia study). Current Medical Research and Opinion. 23: 3055-68. PMID 18196620 DOI: 10.1185/030079907X242809 |
0.339 |
|
| 2007 |
Baum L, Ng MC, So WY, Poon E, Wang Y, Lam VK, Tomlinson B, Chan JC. A case-control study of apoA5 -1131T-->C polymorphism that examines the role of triglyceride levels in diabetic nephropathy. Journal of Diabetes and Its Complications. 21: 158-63. PMID 17493548 DOI: 10.1016/J.Jdiacomp.2006.02.003 |
0.354 |
|
| 2006 |
Ng MCY, Baum L, So WY, Lam VKL, Wang Y, Poon E, Tomlinson B, Cheng S, Lindpaintner K, Chan JCN. Association of lipoprotein lipase S447X, apolipoprotein E exon 4, and apoC3-455T>C polymorphisms on the susceptibility to diabetic nephropathy Clinical Genetics. 70: 20-28. PMID 16813599 DOI: 10.1111/J.1399-0004.2006.00628.X |
0.352 |
|
| 2006 |
Thomas GN, Chan P, Tomlinson B. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension. Drugs & Aging. 23: 131-55. PMID 16536636 DOI: 10.2165/00002512-200623020-00004 |
0.336 |
|
| 2005 |
Yin OQ, Tomlinson B, Chow MS. CYP2C9, but not CYP2C19, polymorphisms affect the pharmacokinetics and pharmacodynamics of glyburide in Chinese subjects. Clinical Pharmacology and Therapeutics. 78: 370-7. PMID 16198656 DOI: 10.1016/J.Clpt.2005.06.006 |
0.327 |
|
| 2005 |
Baum L, Ng MC, So WY, Lam VK, Wang Y, Poon E, Tomlinson B, Cheng S, Lindpaintner K, Chan JC. Effect of hepatic lipase -514C->T polymorphism and its interactions with apolipoprotein C3 -482C->T and apolipoprotein E exon 4 polymorphisms on the risk of nephropathy in chinese type 2 diabetic patients. Diabetes Care. 28: 1704-9. PMID 15983323 DOI: 10.2337/Diacare.28.7.1704 |
0.319 |
|
| 2005 |
Ma YQ, Thomas GN, Tomlinson B. Association of two apolipoprotein A-I gene MspI polymorphisms with lipid and blood pressure levels. International Journal of Cardiology. 102: 309-14. PMID 15982502 DOI: 10.1016/J.Ijcard.2004.10.017 |
0.534 |
|
| 2005 |
Fang YJ, Thomas GN, Xu ZL, Fang JQ, Critchley JA, Tomlinson B. An affected pedigree member analysis of linkage between the dopamine D2 receptor gene TaqI polymorphism and obesity and hypertension. International Journal of Cardiology. 102: 111-6. PMID 15939106 DOI: 10.1016/J.Ijcard.2004.05.010 |
0.522 |
|
| 2005 |
Yin OQ, Shi XJ, Tomlinson B, Chow MS. Effect of cyp2d6*10 allele on the pharmacokinetics of loratadine in chinese subjects. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 33: 1283-7. PMID 15932952 DOI: 10.1124/Dmd.105.005025 |
0.316 |
|
| 2004 |
Zhao HL, Lai FM, Tong PC, Tomlinson B, Chan JC. Clinicopathologic characteristics of nodular glomerulosclerosis in Chinese patients with type 2 diabetes. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 44: 1039-49. PMID 15558525 DOI: 10.1053/J.Ajkd.2004.08.026 |
0.501 |
|
| 2004 |
Cheng CW, Woo KS, Chan JC, Tomlinson B, You JH. Association between adherence to statin therapy and lipid control in Hong Kong Chinese patients at high risk of coronary heart disease. British Journal of Clinical Pharmacology. 58: 528-35. PMID 15521901 DOI: 10.1111/J.1365-2125.2004.02202.X |
0.315 |
|
| 2004 |
Zhao HL, Tong PC, Lai FM, Tomlinson B, Chan JC. Association of glomerulopathy with the 5'-end polymorphism of the aldose reductase gene and renal insufficiency in type 2 diabetic patients. Diabetes. 53: 2984-91. PMID 15504980 DOI: 10.2337/Diabetes.53.11.2984 |
0.519 |
|
| 2004 |
Tomlinson B, Woo J, Thomas GN, Chau YM, Critchley JA. Randomized, controlled, parallel-group comparison of ambulatory and clinic blood pressure responses to amlodipine or enalapril during and after treatment in adult chinese patients with hypertension. Clinical Therapeutics. 26: 1292-304. PMID 15476910 DOI: 10.1016/S0149-2918(04)80145-0 |
0.309 |
|
| 2004 |
Thomas GN, Lin JW, Lam WW, Tomlinson B, Yeung V, Chan JC, Wong KS. Albuminuria is a marker of increasing intracranial and extracranial vascular involvement in Type 2 diabetic Chinese patients. Diabetologia. 47: 1528-34. PMID 15338128 DOI: 10.1007/S00125-004-1490-8 |
0.306 |
|
| 2004 |
Xu L, Siegrist J, Cao W, Li L, Tomlinson B, Chan J. Measuring job stress and family stress in Chinese working women: a validation study focusing on blood pressure and psychosomatic symptoms. Women & Health. 39: 31-46. PMID 15130860 DOI: 10.1300/J013V39N02_03 |
0.472 |
|
| 2004 |
Critchley L, Ding B, Fok B, Wang D, Tomlinson B, James A, Thomas GN, Critchley J. The effects of candesartan and ramipril on adrenal catecholamine release in anaesthetized dogs. European Journal of Pharmacology. 489: 67-75. PMID 15063157 DOI: 10.1016/J.Ejphar.2004.02.036 |
0.628 |
|
| 2004 |
Wachtel-Galor S, Tomlinson B, Benzie IF. Ganoderma lucidum ("Lingzhi"), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study. The British Journal of Nutrition. 91: 263-9. PMID 14756912 DOI: 10.1079/Bjn20041039 |
0.303 |
|
| 2004 |
Cheng C, Woo K, Chan J, Tomlinson B, You J. PCV4 VARIABLE PATIENT COMPLIANCE WITH STATINS AND ASSOCIATED LIPID CONTROL AMONG CHINESE PATIENTS WITH HIGH RISK FOR CORONARY HEART DISEASE Value in Health. 7: 318-319. DOI: 10.1016/S1098-3015(10)62370-4 |
0.309 |
|
| 2004 |
Fang Y, Li C, Fang J, Thomas G, Tomlinson B. 1161-174 Pulse pressure and interactions between polymorphisms in the angiotensin II type 1 receptor and uncoupling protein 1 genes in hypertensive Hong Kong Chinese Journal of the American College of Cardiology. 43: A522. DOI: 10.1016/S0735-1097(04)92213-9 |
0.515 |
|
| 2004 |
Tomlinson B. KS 7 Effects of drugs to increase HDL-Cholesterol International Journal of Cardiology. 97: S4-S5. DOI: 10.1016/S0167-5273(04)80012-3 |
0.309 |
|
| 2003 |
Zhao HL, Thomas GN, Leung W, Tomlinson B, Hsu YH, Chan P. An update on the management of nephropathy in type 2 diabetes. Journal of the Chinese Medical Association : Jcma. 66: 627-36. PMID 14768849 |
0.422 |
|
| 2003 |
Zhao HL, Lai FM, Tong PC, Zhong DR, Yang D, Tomlinson B, Chan JC. Prevalence and clinicopathological characteristics of islet amyloid in chinese patients with type 2 diabetes. Diabetes. 52: 2759-66. PMID 14578294 DOI: 10.2337/Diabetes.52.11.2759 |
0.517 |
|
| 2003 |
Ma YQ, Thomas GN, Ng MC, Critchley JA, Cockram CS, Chan JC, Tomlinson B. Association of two apolipoprotein A-I gene MspI polymorphisms with high density lipoprotein (HDL)-cholesterol levels and indices of obesity in selected healthy Chinese subjects and in patients with early-onset type 2 diabetes. Clinical Endocrinology. 59: 442-9. PMID 14510906 DOI: 10.1046/J.1365-2265.2003.01865.X |
0.548 |
|
| 2003 |
Thomas GN, Lin JW, Lam WW, Tomlinson B, Yeung V, Chan JC, Wong KS. Middle cerebral artery stenosis in type II diabetic Chinese patients is associated with conventional risk factors but not with polymorphisms of the renin-angiotensin system genes. Cerebrovascular Diseases (Basel, Switzerland). 16: 217-23. PMID 12865608 DOI: 10.1159/000071119 |
0.303 |
|
| 2003 |
Tam LS, Fan B, Li EK, Thomas GN, Yim SF, Haines CJ, Tomlinson B. Patients with systemic lupus erythematosus show increased platelet activation and endothelial dysfunction induced by acute hyperhomocysteinemia. The Journal of Rheumatology. 30: 1479-84. PMID 12858444 |
0.475 |
|
| 2003 |
Baum L, Tomlinson B, Thomas GN. APOA5-1131T>C polymorphism is associated with triglyceride levels in Chinese men. Clinical Genetics. 63: 377-9. PMID 12752569 DOI: 10.1034/J.1399-0004.2003.00063.X |
0.338 |
|
| 2003 |
Yang T, Pang CP, Tsang MW, Lam CW, Poon PM, Chan LY, Wu XQ, Tomlinson B, Baum L. Pathogenic mutations of the lipoprotein lipase gene in Chinese patients with hypertriglyceridemic type 2 diabetes. Human Mutation. 21: 453. PMID 12655575 DOI: 10.1002/Humu.9134 |
0.303 |
|
| 2003 |
Ma YQ, Thomas GN, Ng MC, Critchley JA, Chan JC, Tomlinson B. The lipoprotein lipase gene HindIII polymorphism is associated with lipid levels in early-onset type 2 diabetic patients. Metabolism: Clinical and Experimental. 52: 338-43. PMID 12647273 DOI: 10.1053/Meta.2003.50053 |
0.569 |
|
| 2003 |
Fang Y, Neil Thomas G, Xu Z, Fang J, Tomlinson B. An affected pedigree member analysis of the linkage between the Taql polymorphism of the dopamine D2 receptor gene and obesity-related hypertension in Hong Kong Chinese Journal of the American College of Cardiology. 41: 311. DOI: 10.1016/S0735-1097(03)82458-0 |
0.519 |
|
| 2002 |
Ma YQ, Thomas GN, Critchley JA, Lee ZS, Chan JC, Tomlinson B. Association of the D8S282 marker near the lipoprotein lipase gene locus with systolic blood pressure in healthy Chinese subjects. Journal of Hypertension. 20: 2199-204. PMID 12409958 DOI: 10.1097/00004872-200211000-00019 |
0.534 |
|
| 2002 |
Thomas GN, Zhao HL, Ma YQ, Leung WY, Chan JC, Tomlinson B, Critchley JA. Relationship between obesity and cardiovascular risk factors in elderly Chinese subjects. Chinese Medical Journal. 115: 897-9. PMID 12123561 |
0.596 |
|
| 2002 |
Critchley JA, Zhao HL, Tomlinson B, Leung W, Thomas GN, Chan JC, Cockram CS. Management of nephropathy in patients with type 2 diabetes. Chinese Medical Journal. 115: 129-35. PMID 11930647 |
0.436 |
|
| 2002 |
Thomas GN, Critchley JA, Tomlinson B, Cockram CS, Chan JC. Relationships between the taqI polymorphism of the dopamine D2 receptor and blood pressure in hyperglycaemic and normoglycaemic Chinese subjects. Clinical Endocrinology. 55: 605-11. PMID 11894971 DOI: 10.1046/J.1365-2265.2001.01404.X |
0.309 |
|
| 2001 |
Wang DQ, Critchley JA, Ding BG, Ma YQ, Zhao HL, Thomas GN, Tian YP, Tomlinson B, Critchley LA, Edward JA. [Protection against paracetamol-induced hepatic damage using total flavonoids of Astragalus]. Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica. 26: 617-20. PMID 12776431 |
0.715 |
|
| 2001 |
Tomlinson B, Chan P, Lan W. How well tolerated are lipid-lowering drugs? Drugs & Aging. 18: 665-83. PMID 11599634 DOI: 10.2165/00002512-200118090-00003 |
0.557 |
|
| 2001 |
Tomlinson B, Lan W. Hypothyroidism and simvastatin. Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi / Hong Kong Academy of Medicine. 7: 219-20. PMID 11514761 |
0.408 |
|
| 2001 |
Yin OQ, Tomlinson B, Chow AH, Chow MS. Pharmacokinetics of acetaminophen in Hong Kong Chinese subjects. International Journal of Pharmaceutics. 222: 305-8. PMID 11427360 DOI: 10.1016/S0378-5173(01)00712-8 |
0.311 |
|
| 2001 |
Ma YQ, Thomas GN, Critchley JA, Chan JC, Lee ZS, Tomlinson B. Identification of the intron 14 splicing defect of the cholesteryl ester transfer protein gene in Hong Kong Chinese. Clinical Genetics. 59: 287-9. PMID 11298687 DOI: 10.1034/J.1399-0004.2001.590413.X |
0.466 |
|
| 2001 |
Thomas GN, Tomlinson B, Chan JC, Sanderson JE, Cockram CS, Critchley JA. Renin-angiotensin system gene polymorphisms, blood pressure, dyslipidemia, and diabetes in Hong Kong Chinese: a significant association of tne ACE insertion/deletion polymorphism with type 2 diabetes. Diabetes Care. 24: 356-61. PMID 11213892 DOI: 10.2337/Diacare.24.2.356 |
0.331 |
|
| 2000 |
Tomlinson B, Chan TY, Chan JC, Critchley JA, But PP. Toxicity of complementary therapies: an eastern perspective. Journal of Clinical Pharmacology. 40: 451-6. PMID 10806596 DOI: 10.1177/00912700022009206 |
0.301 |
|
| 1998 |
Mak Y, Pang C, Tomlinson B, Zhang J, Chan Y, Mak TWL, Masarei JRL. Mutations in the Low-Density Lipoprotein Receptor Gene in Chinese Familial Hypercholesterolemia Patients Arteriosclerosis, Thrombosis, and Vascular Biology. 18: 1600-1605. PMID 9763532 DOI: 10.1161/01.Atv.18.10.1600 |
0.311 |
|
| 1998 |
Young RP, Thomas GN, Critchley JAJH, Tomlinson B, Woo KS, Sanderson JE. Interethnic Differences in Coronary Heart Disease Mortality in 25 Populations: Association with the Angiotensin-Converting Enzyme DD Genotype Frequency European Journal of Cardiovascular Prevention & Rehabilitation. 5: 303-307. DOI: 10.1177/174182679800500503 |
0.307 |
|
| 1998 |
Mok PH, Tomlinson B, Lan W, Sanderson JE, Woo KS. P094 Lipid abnormalities and their treatment in patients with acute myocardial infarction in Hong Kong Atherosclerosis. 136: S72. DOI: 10.1016/S0021-9150(97)84666-7 |
0.502 |
|
| 1998 |
Tomlinson B, Lan W, Mak Y, Chan Y, Mak TW-, Critchley JAJH, Maserei JRL, Pang C. F049 Familial hypercholesterolaemia in Hong Kong Atherosclerosis. 136. DOI: 10.1016/S0021-9150(97)84626-6 |
0.465 |
|
| 1998 |
Tomlinson B, Wong S, Lan W, Critchley JA, Mak TW, Lam CW, Woo KS, Sanderson JB. F038 Combination treatment with fluvastatin and gemfibrozil in resistant hyperlipidaemia Atherosclerosis. 136: S56. DOI: 10.1016/S0021-9150(97)84615-1 |
0.465 |
|
| 1998 |
Lan W, Tomlinson B, Chau Y, Say T, Lee KK, Critchley JA, Mak TW, Lam CW. F036 Response to bezafibrate in combined hyperlipidaemia Atherosclerosis. 136: S55. DOI: 10.1016/S0021-9150(97)84609-6 |
0.46 |
|
| 1997 |
Anderson PJ, Chan JC, Chan YL, Tomlinson B, Young RP, Lee ZS, Lee KK, Metreweli C, Cockram CS, Critchley JA. Visceral fat and cardiovascular risk factors in Chinese NIDDM patients. Diabetes Care. 20: 1854-8. PMID 9405906 DOI: 10.2337/Diacare.20.12.1854 |
0.301 |
|
| 1997 |
Chan P, Lin CN, Tomlinson B, Lin TH, Lee YS. Additive effects of diltiazem and lisinopril in the treatment of elderly patients with mild-to-moderate hypertension. American Journal of Hypertension. 10: 743-9. PMID 9234828 DOI: 10.1016/S0895-7061(96)00060-X |
0.309 |
|
| 1997 |
Chan P, Huang TY, Tomlinson B, Lee C, Lee YS. Short‐Term Safety and Efficacy of Low‐Dose Simvastatin in Elderly Patients with Hypertensive Hypercholesterolemia and Fasting Hyperinsulinemia The Journal of Clinical Pharmacology. 37: 496-501. PMID 9208356 DOI: 10.1002/J.1552-4604.1997.Tb04327.X |
0.342 |
|
| 1997 |
Chan JC, Critchley JA, Tomlinson B, Chan TY, Cockram CS. Antihypertensive and anti-albuminuric effects of losartan potassium and felodipine in Chinese elderly hypertensive patients with or without non-insulin-dependent diabetes mellitus. American Journal of Nephrology. 17: 72-80. PMID 9057957 DOI: 10.1159/000169075 |
0.305 |
|
| 1997 |
Tomlinson B, Wong S, Lan W, Critchley J, Mak T, Lam C, Woo K, Sanderson J. 1.P.217 Effects of fluvastatin alone and in combination with gemfibrozil on lipids and glucose tolerance in resistant hyperlipidaemia Atherosclerosis. 134: 62. DOI: 10.1016/S0021-9150(97)88396-7 |
0.499 |
|
| 1996 |
Chan P, Tomlinson B, Lee CB, Pan WH, Lee YS. Beneficial effects of pravastatin on fasting hyperinsulinemia in elderly hypertensive hypercholesterolemic subjects. Hypertension (Dallas, Tex. : 1979). 28: 647-51. PMID 8843892 DOI: 10.1161/01.Hyp.28.4.647 |
0.332 |
|
| 1996 |
Haines CJ, Chung TK, Masarei JR, Tomlinson B, Lau JT. An examination of the effect of combined cyclical hormone replacement therapy on lipoprotein(a) and other lipoproteins. Atherosclerosis. 119: 215-22. PMID 8808498 DOI: 10.1016/0021-9150(95)05650-5 |
0.305 |
|
| 1996 |
Chan P, Tomlinson B, Lee CB, Lee YS. Effectiveness and safety of low-dose pravastatin and squalene, alone and in combination, in elderly patients with hypercholesterolemia Journal of Clinical Pharmacology. 36: 422-427. PMID 8739021 DOI: 10.1002/J.1552-4604.1996.Tb05029.X |
0.343 |
|
| 1995 |
Tomlinson B, Mak TW, Tsui JY, Woo J, Shek CC, Critchley JA, Masarei JR. Effects of fluvastatin on lipid profile and apolipoproteins in Chinese patients with hypercholesterolemia. The American Journal of Cardiology. 76: 136A-139A. PMID 7604789 DOI: 10.1016/S0002-9149(05)80036-0 |
0.357 |
|
| 1994 |
Chan JC, Yeung VT, Leung DH, Tomlinson B, Nicholls MG, Cockram CS. The effects of enalapril and nifedipine on carbohydrate and lipid metabolism in NIDDM. Diabetes Care. 17: 859-62. PMID 7956631 DOI: 10.2337/Diacare.17.8.859 |
0.318 |
|
| 1994 |
Tomlinson B, Mak T, Tsui J, Woo J, Shek C, Critchley J, Masarei J. Effects of fluvastatin on lipid profile and apolipoproteins in Chinese patients with hypercholesterolemia Atherosclerosis. 109: 320. DOI: 10.1016/0021-9150(94)94284-6 |
0.328 |
|
| Show low-probability matches. |